Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
Mesenchymal stem cells (MSCs) have a potently immunosuppressive capacity in both innate and adaptive immune responses. Consequently, MSCs transplantation has emerged as a potential beneficial therapy for autoimmune diseases even though the mechanisms underlying the immunomodulatory activity of MSCs...
Main Authors: | Rui-Juan Cheng, An-Ji Xiong, Yan-Hong Li, Shu-Yue Pan, Qiu-Ping Zhang, Yi Zhao, Yi Liu, Tony N. Marion |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00285/full |
Similar Items
-
Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
by: Yantong Zhu, et al.
Published: (2018-05-01) -
Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy
by: Valentina Turinetto, et al.
Published: (2016-07-01) -
Chronological Age Affects MSC Senescence In Vitro—A Systematic Review
by: Konstantinos Kapetanos, et al.
Published: (2021-07-01) -
Lupus Enteritis: An Uncommon Manifestation of Systemic Lupus Erythematosus as an Initial Presentation
by: Vishal Bodh, et al.
Published: (2017-07-01) -
Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
by: Tianbiao Zhou, et al.
Published: (2020-02-01)